Just – Evotec Biologics
Seattle, WA (US HQ; EU manufacturing: Toulouse, France)
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (10)
○ EMA GMP
○ MHRA GMP
Quick Facts: Just – Evotec Biologics
- Signal Score
- 60.0/100
- Quality Compliance
- Assessment pending
- Headquarters
- Seattle, WA (US HQ; EU manufacturing: Toulouse, France)
- Modalities
- Monoclonal Antibody, Bispecific / Multispecific Antibody, Fc-Fusion Protein, Biosimilars, Recombinant Protein
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Just – Evotec Biologics
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesMonoclonal Antibody, Bispecific / Multispecific Antibody, Fc-Fusion Protein, Biosimilars, Recombinant Protein
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (5 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press10 articles
Broad modality coverage (5 modalities)
Recent News 10 articles
Evotec Inks Sale of Just – Evotec Biologics Toulouse Site to Sandoz - Contract Pharma
Evotec's reorg claims 600 jobs, hundreds more than originally planned - Fierce Biotech
Just – Evotec Biologics wins up to $10m BARDA backing for Ebola antibody manufacturing - drugdiscoverynews.com
BARDA Contracts Just – Evotec to Optimize Biomanufacturing of Antibodies Against Filovirus - Contract Pharma
Just - Evotec Biologics Enters Project Agreement with BARDA to Optimize Biomanufacturing of Antibodies Against Ebola and Related Viruses - Yahoo Finance
Interview with Just - Evotec Biologics at BIO-Europe 2025 - Evotec
Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook - TradingView
Sandoz bolsters in-house biosimilar manufacturing with Evotec acquisition - Pharmaceutical Technology
Just – Evotec Biologics opens new J.POD facility in France - BioProcess International
Just - Evotec Biologics: Innovative and Trusted Biologics CDMO - bioxconomy.com
Frequently Asked Questions About Just – Evotec Biologics
What is Just – Evotec Biologics's CDMO Signal Score?
Just – Evotec Biologics has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Just – Evotec Biologics for a manufacturing program?
Use the free AI matchmaker to compare Just – Evotec Biologics against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Mabion S.A.
Konstantynów Łódźki, Poland
Monoclonal Antibody, Recombinant Protein, Biosimilars, Vaccine Antigens, ADC / PDC (analytics & development), Sterile Fill-Finish
EirGenix
Zhubei City, Taiwan
Monoclonal Antibody, Bispecific/Polyclonal Antibody, Recombinant Protein, ADC, Biosimilars, Plasmid DNA
Boehringer Ingelheim BioXcellence
Ingelheim am Rhein, Germany
Monoclonal Antibody, Bispecific Antibody, Recombinant Protein, Antibody Fragments, Biosimilars, Biologics
Kemwell Biopharma
Bengaluru, India
Monoclonal Antibody, Bispecific Antibody, Recombinant Protein, Biosimilars, Cell Therapy, Sterile Fill-Finish
Kemwell Biopharma, Bangalore
Bengaluru, India
Monoclonal Antibody, Bispecific Antibody, Recombinant Protein, Biosimilars, Cell Therapy, Sterile Fill-Finish, Lyophilized Drug Product